Daniel Kaplan
Chief Tech/Sci/R&D Officer bij NGM BIOPHARMACEUTICALS, INC.
Oorsprong van het eerstegraads netwerk van Daniel Kaplan
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 30 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Daniel Kaplan via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Human Resources Officer | |
| SENOMYX INC. | Food: Specialty/Candy | Chairman Director/Board Member | |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
| Three Crowns Capital Bermuda Ltd. | Founder | ||
| AMYRIS, INC. | Chemicals: Specialty | Chairman Corporate Officer/Principal | |
| PELOTON THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Doctorate Degree | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Corporate Officer/Principal Undergraduate Degree | |
| XENOPORT, INC. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
| The University of Texas at Austin | College/University | Masters Business Admin | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Doctorate Degree | |
| Princeton University | College/University | Doctorate Degree Undergraduate Degree | |
| University of Toronto | College/University | Doctorate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Doctorate Degree Doctorate Degree | |
| University of California San Diego | College/University | Undergraduate Degree Undergraduate Degree | |
| University of California, Santa Barbara | College/University | Undergraduate Degree Undergraduate Degree | |
| ANACOR PHARMACEUTICALS INC | Pharmaceuticals: Major | Chairman Director/Board Member | |
| World Presidents' Organization | Corporate Officer/Principal | ||
| Southwestern Medical Foundation | Investment Trusts/Mutual Funds | Director/Board Member | |
The Column Group LLC
 The Column Group LLC Investment ManagersFinance The Column Group LLC is a venture capital firm founded in 2005 by Peter Svennilson. The firm is headquartered in San Francisco. | Investment Managers | Corporate Officer/Principal Private Equity Investor Private Equity Investor Founder Private Equity Investor | |
| CONSTELLATION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| East China University of Science & Technology | College/University | Undergraduate Degree Undergraduate Degree | |
| IMMUNE DESIGN CORP | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| The University of Texas Southwestern Medical Center | College/University | Doctorate Degree Corporate Officer/Principal | |
| Harvard Medical School | College/University | Doctorate Degree Corporate Officer/Principal | |
Tichenor Ventures LLC
 Tichenor Ventures LLC Investment ManagersFinance Tichenor Ventures LLC (Tichenor Ventures) is a venture capital firm founded in 2009. The firm is headquartered in Dallas, Texas. | Investment Managers | President | |
Carmot Therapeutics, Inc.
 Carmot Therapeutics, Inc. BiotechnologyHealth Technology Carmot Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of therapeutics for metabolic diseases, cancer, and inflammation. Its pipeline includes CT-388, CT-996, and CT-868. The CT-388 refers to treatment taken once-weekly subcutaneous injectable for obesity and type 2 diabetes (T2D). The CT-996 comprises of once-daily oral treatment for obesity and T2D. The CT-868 consists of once-daily subcutaneous injectable for treatment of type 1 diabetes (T1D) patients with overweight or obesity. The company was founded in 2008 and is headquartered in Berkeley, CA. | Biotechnology | Director/Board Member Director/Board Member | |
| Sarcoma Alliance for Research through Collaboration | Chairman | ||
| The University of Chicago Booth School of Business | College/University | Graduate Degree Masters Business Admin | |
| Zhongshan Hospital Fudan University | College/University | Doctorate Degree Graduate Degree | |
| ADAGENE INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Stanford University School of Medicine | College/University | Graduate Degree Doctorate Degree | |
| Stanford Graduate School of Business | College/University | Masters Business Admin Masters Business Admin | |
| ORIC PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Human Resources Officer | |
Ribon Therapeutics, Inc.
 Ribon Therapeutics, Inc. BiotechnologyHealth Technology Ribon Therapeutics, Inc. operates as a biotechnology company which focuses on developing therapeutics targeting monoADP-ribosylating PARPs for cancer. Its medicines are used for blocking cancer cells? fundamental survival mechanisms. The company was founded by W. Lee Kraus, Tim Mitchison and Paul Chang in 2015 and is headquartered in Lexington, MA. | Biotechnology | Director/Board Member | |
| RAPT THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
Iconica LLC
 Iconica LLC Investment ManagersFinance Iconica LLC (Iconica Partners) is a venture capital firm founded in 2015. The firm is headquartered in Palo Alto, California. | Investment Managers | Private Equity Investor Private Equity Investor | |
Surrozen Operating, Inc.
 Surrozen Operating, Inc. BiotechnologyHealth Technology Surrozen Operating, Inc. operates as a biopharmaceutical company that focuses on harnessing the Wnt pathway for applications in regenerative medicine. The firm implements a surrogate Wnt platform with the potential to unlock stem cell control in an array of human tissues. The company was founded by K. Christopher Garcia, Roeland Nusse, Calvin J. Kuo, Hans Claudia and Claudia Janda in 2015 and is headquartered in South San Francisco, CA. | Biotechnology | Chairman Director/Board Member | |
Exonics Therapeutics, Inc.
 Exonics Therapeutics, Inc. BiotechnologyHealth Technology Exonics Therapeutics, Inc. develops therapies for neuromuscular diseases. It also develops gene editing technologies like CRISPR/Cas9 to permanently correct the majority of duchenne muscular dystrophy mutations. The company was founded by Eric N. Olson in February 2017 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Chairman | |
A2 Biotherapeutics, Inc.
 A2 Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services A2 Biotherapeutics, Inc. operates as a biotechnology company. It develops medicines. The company was founded by Alexander Kamb, Michael Gallo and Paul Kang in 2018 and is headquartered in Westlake Village, CA. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| SURROZEN, INC. | Biotechnology | Director/Board Member Chairman | |
| TENAYA THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 46 |
| China | 4 |
| Bermuda | 2 |
| Canada | 2 |
Sectoraal
| Health Technology | 23 |
| Consumer Services | 17 |
| Commercial Services | 4 |
| Finance | 4 |
| Consumer Non-Durables | 2 |
Operationeel
| Director/Board Member | 156 |
| Corporate Officer/Principal | 79 |
| Independent Dir/Board Member | 40 |
| Chairman | 29 |
| Undergraduate Degree | 27 |
Sterkste connecties
| Insiders | |
|---|---|
| Mark Leschly | 36 |
| Helen Kim | 33 |
| David Goeddel | 27 |
| Peter Svennilson | 25 |
| David Schnell | 25 |
| Roger Perlmutter | 19 |
| Arthur Levinson | 19 |
| McHenry Tichenor | 17 |
| William Rieflin | 16 |
| Jeffrey Jonker | 16 |
| Hsiao Lieu | 11 |
| Suzanne Hooper | 10 |
| Siobhan Mangini | 10 |
| Valerie Pierce | 9 |
| Shelly Guyer | 9 |
- Beurs
- Insiders
- Daniel Kaplan
- Bedrijfsconnecties
